DIA400.98+5.07 1.28%
SPX5,484.77+108.91 2.03%
IXIC17,166.04+457.99 2.74%

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga·12/24/2024 21:06:14
Listen to the news

Gainers

  • Avinger (NASDAQ:AVGR) stock increased by 169.3% to $1.73 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.5 million.
  • Carmell (NASDAQ:CTCX) stock moved upwards by 85.32% to $0.42. The company's market cap stands at $8.7 million.
  • Tivic Health Systems (NASDAQ:TIVC) stock rose 69.47% to $0.38. The market value of their outstanding shares is at $3.1 million.
  • NeueHealth (NYSE:NEUE) shares rose 63.57% to $7.05. The market value of their outstanding shares is at $58.4 million.
  • 180 Life Sciences (NASDAQ:ATNF) shares rose 39.03% to $2.6. The company's market cap stands at $5.1 million.
  • Theriva Biologics (AMEX:TOVX) shares increased by 23.07% to $1.6. The market value of their outstanding shares is at $4.4 million.

Losers

  • KalVista Pharma (NASDAQ:KALV) stock fell 20.7% to $7.0 during Tuesday's pre-market session. The company's market cap stands at $345.9 million.
  • Anebulo Pharmaceuticals (NASDAQ:ANEB) shares declined by 16.0% to $1.05. The market value of their outstanding shares is at $27.2 million.
  • Dogwood Therapeutics (NASDAQ:DWTX) stock declined by 13.61% to $2.35. The company's market cap stands at $3.1 million.
  • Traws Pharma (NASDAQ:TRAW) stock fell 12.1% to $11.05. The market value of their outstanding shares is at $33.4 million.
  • Astria Therapeutics (NASDAQ:ATXS) stock fell 11.77% to $8.4. The market value of their outstanding shares is at $474.0 million.
  • Ocean Biomedical (NASDAQ:OCEA) stock fell 11.74% to $0.56. The company's market cap stands at $19.6 million. The company's, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.